Shows
The ConcertAI PodcastFrom Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology TrialsIn this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and the strategic shift toward real-time decision-making, this conversation is essential listening for anyone in translational medicine or clinical development. Websitewww.ConcertAI.com2025-04-1621 min
Health News TrackerTransforming US Healthcare: Navigating Costs, Regulations, and Digital InnovationsThe U.S. healthcare industry is undergoing significant developments in the past 48 hours, driven by market trends, regulatory upheavals, and technological advancements.Medical costs are projected to rise in 2025, with an 8% growth for the group market and 7.5% for individuals, largely fueled by inflation, increased drug spending, and higher demand for behavioral health services. Adjustments in Medicaid and ACA enrollment, along with the Inflation Reduction Act’s price-setting framework, are also reshaping cost structures, with potential long-term impacts on drug pricing and healthcare affordability[2].On the regulatory front, the Department of Health and Human Services (HHS) is ex...2025-04-0302 minThe ConcertAI PodcastThe Future of Drug Development: AI, RWD, and Regulatory Insights feat. Evidera's Ariel BergerIn this episode of The ConcertAI Podcast, Jeff Elton, CEO of ConcertAI, engages with Ariel Berger, Executive Director of Integrated Solutions of Evidera, part of the PPD™ clinical research business of Thermo Fisher Scientific, to explore the innovative uses of real-world data (RWD) in regulatory settings, particularly in oncology. They discuss the critical role of RWD in shaping clinical trials and supporting regulatory decisions, emphasizing its growing importance in the regulatory approval process. The conversation also delves into the complexities of integrating AI and advanced data technologies to enhance trial designs and outcomes, highlighting how these tools are revolutionizing dr...2025-03-3142 minThe ConcertAI PodcastAccelerating Healthcare Innovation with NVIDIA feat. Rory KelleherIn the season three opener of The ConcertAI Podcast, our guest Rory Kelleher (Senior Director, Global Head of Business Development, Life Sciences) from NVIDIA delves into the transformative role of AI in healthcare and life sciences. With a rich background at NVIDIA, Rory shares insights into NVIDIA’s journey from a GPU manufacturer to a leader in AI computation. This episode explores NVIDIA’s initiatives like the Clara platform, which seamlessly integrates AI into medical imaging and genomics, significantly accelerating drug discovery and patient care processes. Rory and host, Jeff Elton, discuss the collaborative dynamics between ConcertAI and NVIDIA, focu...2025-03-1844 min
ThinkData PodcastS3 | E1 | Transforming Research and Care within Healthcare through AI - Jeff Elton - CEO @ ConcertAIWelcome to the first episode of Season 3 of the ThinkData Podcast in partnership with Dataworks. the ThinkData Podcast in partnership with Dataworks. On today’s show, I’m excited to welcome Jeff Elton, the CEO of ConcertAI, a global leader in Clinical AI and Real-World Data solutionsJeff has a wealth of experience in the Life sciences and health space, having worked for Accenture, Novartis, and McKinsey and lectured at Boston University. Jeff's background and what led him to become the CEO of ConcertWho is ConcertAI and what problem does his business solve?The chal...2025-01-0633 minThe ConcertAI PodcastProstate Cancer Awareness with Steve Osunsami: Screening, Survival, and Breaking StigmasIn this compelling episode of The ConcertAI Podcast, host Jeff Elton sits down with ABC's senior national correspondent, Steve Osunsami, to discuss the critical importance of prostate cancer screening and awareness. Steve shares his personal journey with prostate cancer, from initial diagnosis at age 41 to treatment and recovery. He highlights the significance of early detection, particularly for high-risk groups such as African American men, and the life-saving potential of regular PSA testing. Through his candid storytelling, Steve addresses the the challenges men face regarding prostate cancer, including the stigma around sexual function, and advocates for increased awareness and proactive...2024-09-1740 minThe ConcertAI PodcastBreaking New Ground in Prostate Cancer Research feat. Jennifer Rider and Kathryn PenneySeptember marks Prostate Cancer Awareness Month, and to honor this, our latest episode of the ConcertAI Podcast features a special session with top urological cancer specialists. Host Jeff Elton welcomes Jennifer Rider and Kathryn Penney to our studio in Harvard Square, Cambridge, MA. Both guests are distinguished cancer epidemiologists who bring a wealth of knowledge and experience in prostate cancer research. In this episode, you will hear about the personal journeys of our guests into the field of cancer research, the significant advancements they have contributed to, and the vital role of genetic studies in improving patient c...2024-09-0524 min
Outcomes RocketHow ConcertAI is Revolutionizing Cancer Research with AI with Jeff Elton, CEO of ConcertAIData integration and AI play crucial roles in predicting and managing treatment resistance in diseases like cancer.In this episode, Jeff Elton, CEO of ConcertAI, discusses his team’s focus on oncology and its role in accelerating medical research and improving patient care. He highlights the importance of data integration and AI in understanding diseases like cancer, particularly in predicting and managing treatment resistance. Jeff explains how ConcertAI's technology enables real-time analysis of patient data, aiding in clinical decision-making and trial matching, and delves into setbacks faced in developing AI models, emphasizing the need for transparent and re...2024-06-1723 minThe ConcertAI PodcastCancerLinQ's Transformational Role in Oncology with Dr. Robert MillerJeff Elton sits down with Dr. Robert Miller, Chief Medical and Science Officer at CancerLinQ, to unpack the integration of real-world data and AI in oncology care. Dr. Miller shares his journey from community practice to shaping CancerLinQ, revealing insights into the network's growth and its pivotal role in improving patient care. The episode delves into the transformation of quality measures, the burgeoning role of electronic health records, and the automation of data to enhance the quality and reach of oncological care. As CancerLinQ evolves, discover its expanding capabilities, the drive towards patient-centric care, and the influence on CancerLinQ's...2024-03-1234 minThe ConcertAI PodcastEvolution in Oncology Care feat. Dr. George W. Sledge, Jr.Jeff Elton, CEO of ConcertAI, and George Sledge, CMO of Caris Life Sciences, embark on an insightful journey through the advancements in oncology. They explore the transformative power of molecular diagnostic testing and how comprehensive data sets are revolutionizing personalized medicine. Delving into topics like the rise of liquid biopsies, which enable non-invasive, next-gen sequencing, they highlight the potential for easier and safer tumor monitoring. Challenges like the limitations of analyzing small populations are addressed, emphasizing the value of large-scale, actionable databases in understanding diseases like breast cancer. They also discuss the future of molecular diagnostics in streamlining cancer...2024-02-2130 minThe ConcertAI PodcastNext-Gen Oncology: Caris Life Sciences & ConcertAI's Vision feat. Dr. David SpetzlerIn this engaging episode, David Spetzler, President of Caris Life Sciences, and Jeff Elton, CEO of ConcertAI, discuss the transformative power of combining clinical insights and advanced AI technologies to revolutionize patient care in oncology. Highlighting their collaborative efforts, they emphasize the critical role of comprehensive data analysis, from leveraging longitudinal clinical records to employing next-generation sequencing for personalized treatment strategies. The conversation underscores a shared commitment to advancing medical science by accelerating the development and validation of new therapies, ultimately aiming to enhance patient outcomes through precision medicine. Through this partnership, they envision a future where diagnostics and...2024-02-1525 minThe ConcertAI PodcastEmpowering Community Oncology: Challenges & InnovationsThe second episode of The ConcertAI Podcast features Dr. Sibel Blau and Caroline Merillat, key figures in the Quality Cancer Care Alliance (QCCA) and creators of Exigent. This initiative aims to improve clinical research in community oncology, making trials more accessible and reflective of standard care populations. Dr. Blau, motivated by a dream to cure cancer, emphasized the importance of maintaining the independence of oncology practices for superior patient care. Merillat, with extensive experience in research, is dedicated to expanding trial access, especially for underserved populations. Exigent, by leveraging real-world data and collaborative efforts, seeks to enhance trial quality...2024-02-0836 min
The Harry Glorikian ShowHow ConcertAI Came to Lead in Cancer DataIf you look back at all the health-tech and drug development companies Harry has hosted on the show, an interesting pattern starts to emerge: a very large number of those companies have gone on to enormous growth and success in their markets. It could be that being on the podcast is like a catapult to success—or it could be that we're pretty good at finding companies that are already on a promising trajectory. Either way, there's no better example than Concert AI. The company’s CEO, Jeff Elton, first spoke with Harry back in July of 2021. At th...2024-01-301h 00The ConcertAI PodcastReal-World Data in Oncology: Navigating the New Frontiers feat. Jennifer RiderIn this captivating episode of The ConcertAI Podcast, we dive deep with Jennifer Rider, a renowned cancer epidemiologist. Jennifer shares her journey from academia to the dynamic world of real-world data (RWD) and its vital role in oncology research. We explore how RWD is transforming the landscape of prostate cancer studies and its increasing importance in regulatory decision-making.Discover how the field of RWD has evolved and its pivotal contributions to the development and application of groundbreaking oncology treatments. Jennifer's insights into the integration of RWD in clinical trials and its potential to shape future cancer therapies...2024-01-3033 minThe ConcertAI PodcastSeason 2 IntroductionWe're back with The ConcertAI Podcast for Season Two! In our first episodes, we delve deep into RWE's role in regulatory applications, such as designing registrational clinical trials and developing robust data sets that shape trial designs and submissions. We're exploring the evolving landscape of efficacy, safety, and the use of external control arms, especially in light of recent FDA guidance.But that's not all. Season Two also highlights incredible progress in clinical trial networks and technologies, especially those facilitating trials in community settings. We're excited to feature Exigent, a key partner in the development of...2024-01-2502 min
DeviceTalks Podcast NetworkThe episode where Mayo Clinic & Anumana transform ECG with AI; ConcertAI dishes on next-gen trialsWelcome to DeviceTalks AI, a DeviceTalks podcast offering a comprehensive look into the intersection of AI and the medical device industry from two unique perspectives.
In the first segment, Paul Friedman, MD, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, and Dave McMullin, Chief Business Officer of Anumana, discuss the groundbreaking collaboration between Mayo Clinic and Anumana in applying AI to enhance cardiovascular diagnostics, particularly through ECGs. They explore how AI can detect cardiac conditions early, with a focus on the EAGLE study's findings on AI-enhanced ECGs, and discuss Anumana's role in transforming these AI innovations into accessible...2023-11-151h 07DeviceTalks Podcast NetworkThe episode where Mayo Clinic & Anumana transform ECG with AI; ConcertAI dishes on next-gen trialsWelcome to DeviceTalks AI, a DeviceTalks podcast offering a comprehensive look into the intersection of AI and the medical device industry from two unique perspectives.
In the first segment, Paul Friedman, MD, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, and Dave McMullin, Chief Business Officer of Anumana, discuss the groundbreaking collaboration between Mayo Clinic and Anumana in applying AI to enhance cardiovascular diagnostics, particularly through ECGs. They explore how AI can detect cardiac conditions early, with a focus on the EAGLE study's findings on AI-enhanced ECGs, and discuss Anumana's role in transforming these AI innovations into accessible...2023-11-151h 07
Career Sessions, Career LessonsUsing AI To Improve Cancer Outcomes, With Jeff EltonWe are seeing more and more solutions to problems as technology continues to evolve and advance. With the growth of artificial intelligence, we are adding tools to gather more data and insights into even the most complex problems. This episode’s guest is proof of that, using AI to improve cancer outcomes. Jeff Elton is the CEO of ConcertAI, whose mission is to accelerate insights and improve outcomes for patients through leading real-world data, AI technologies, and scientific research. He talks more about this to J.R. Lowry along with the other uses of AI in the business. Jeff al...2023-05-2950 min
CM ConversationsLessons from Leaders in Life Science: Talking Talent Strategy.In this episode, Jack speaks with Synda Clements, Director of Talent Acquisition at ConcertAI. This was a great discussion about Talent Strategy and it's importance, using data to inform hiring decisions and key learnings and challenges from her years in the industry.From learning on the job in recruitment to finding her niche in Life Science, Synda has a brilliant and insightful story to tell with plenty of tips for those looking to climb the ladder in talent acquisition. Touching on key topics such as overcoming hiring shortages during economic challenges, how to use marketing in...2023-05-1633 minThe ConcertAI PodcastThe Future of Digital Pathology with PathAI feat. Dr. Andy BeckIn this episode, we're thrilled to have Dr. Andy Beck, the Co-founder and CEO of PathAI, one of the leading digital pathology companies, as our guest.Digital pathology is transforming the accessibility of decision rules and decision augmentation, creating translational assets and changing how clinical development occurs. Dr. Beck shares insights on the progress and life of digital pathology, and how it's transforming healthcare.With the level of data and insights available to medical professionals, clinical interpretation will move far earlier, bringing a sense of optimism for cancer patients everywhere.Tune in to...2023-04-2836 minThe ConcertAI PodcastExploring the Future of Clinical Trials pt. 2 feat. Bristol Myers Squibb's Marisa Co and Gaelan RitterIn this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are changing the game.Bristol Myers Squibb's Marisa and Gaelan share how their collaboration with ConcertAI on the Digitally Accelerated Clinical Trial Solution (DACT) is lowering the burden on patients and sites, and increasing the number of clinical trial types that can be run in community settings. The platform not only meets FDA imperatives but also makes much-needed medicines available to a wider array of patients.Join us a...2023-04-1825 minThe ConcertAI PodcastExploring the Future of Clinical Trials pt. 1 feat. Bristol Myers Squibb's Marisa Co and Gaelan RitterA 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model. In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, and Gaelan Ritter, Head of Analytics Innovation and Digital Health, who shed light on the exciting ways clinical trials are evolving and improving patient outcomes. The team at Bristol Myers Squibb will be discussing their groundbreaking work using the Digitally Accelerated Clinical Trial (DACT) model in the biopharma industry which leverages automation and integrates with various clinical data sources to collect more data and improve t...2023-04-1833 minThe ConcertAI PodcastExploring Globalization and the Power of Biopharma Innovation feat. Jitendra GuptaConcertAI is grateful to have a presence in a geography with such a fast pace of technical innovation, and is excited for the future. Tune in to the latest episode of The ConcertAI Podcast, hosted by CEO Jeff Elton! This week's episode explores the topic of globalizing healthcare and biopharma technical innovation. Jeff and Jitendra Gupta talks about what it really means to be a global company, and the amazing progress that India has made in advancing the healthcare and biopharma technology industry. Don't miss out on this insightful episode!Websitewww.ConcertAI...2023-04-0323 min